Gyre Therapeutics (GYRE) EPS (Basic) (2010 - 2026)
Gyre Therapeutics (GYRE) posted quarterly EPS (Basic) of -$0.1 for Q1 2026, down 404.85% year-over-year from $0.03 in Q1 2025, and down 393.52% quarter-over-quarter from -$0.02 in Q4 2025.
Gyre Therapeutics (GYRE) EPS (Basic) (2010 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has reported EPS (Basic) for 17 consecutive years, with -$0.1 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 404.85% year-over-year to -$0.1; the TTM figure through Mar 2026 stood at -$0.07 (down 183.03% YoY), while the FY2025 annual figure was $0.06, down 60.38% from the prior year.
- EPS (Basic) retreated to -$0.1 in Q1 2026 per GYRE's latest filing, from -$0.02 in the prior quarter.
- Across five years, EPS (Basic) topped out at $24.6 in Q2 2022 and bottomed at -$14.22 in Q4 2022.
- Historically, EPS (Basic) has averaged $0.17 across 5 years, with a median of $0.01 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) jumped 358.04% — and 2025, when it slumped 1557.62%.
- Gyre Therapeutics' EPS (Basic) stood at -$14.22 in 2022, then soared by 89.21% to -$1.53 in 2023, then jumped by 99.92% to -$0.0 in 2024, then tumbled by 1557.62% to -$0.02 in 2025, then tumbled by 393.52% to -$0.1 in 2026.
- Business Quant data shows GYRE's EPS (Basic) at -$0.1 in Q1 2026, -$0.02 in Q4 2025, and $0.04 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn | -0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.12 |
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | -0.02 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | -1.53 |
| Sep 30, 2023 | 1.57 |
| Jun 30, 2023 | 0.74 |
| Mar 31, 2023 | 0.89 |
| Dec 31, 2022 | -14.22 |
| Sep 30, 2022 | -2.33 |
| Jun 30, 2022 | 24.60 |
| Mar 31, 2022 | -6.93 |
| Dec 31, 2021 | -10.28 |
| Sep 30, 2021 | -12.06 |